Syk Activation in Dendritic Cells is Essential for Airway Hyperresponsiveness and Inflammation.
From: Department of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO, 80206, USA.
American journal of respiratory cell and molecular biology
- Publish Date: Apr 2006
- ISSN: 1044-1549
- Volume: 34
- Issue: 4
- Pages: 426-33
- Medium: Print
- Language: English
- Citation (JAMA): Matsubara Shigeki, Koya Toshiyuki, Takeda Katsuyuki, et al. Syk Activation in Dendritic Cells is Essential for Airway Hyperresponsiveness and Inflammation.. Am. J. Respir. Cell Mol. Biol. Apr 2006;34:426-33
Abstract
We evaluated the role of Syk, using an inhibitor, on allergen-induced airway hyperresponsiveness (AHR) and airway inflammation in a system shown to be B cell- and mast cell-independent. Sensitization of BALB/c mice with ovalbumin (OVA) and alum after three consecutive OVA challenges resulted in AHR to inhaled methacholine and airway inflammation. The Syk inhibitor R406 (30 mg/kg, administered orally, twice daily) prevented the development of AHR, increases in eosinophils and lymphocytes and IL-13 levels in bronchoalveolar lavage (BAL) fluid, and goblet cell metaplasia when administered after sensitization and before challenge with OVA. Levels of IL-4, IL-5, and IFN-gamma in BAL fluid and allergen-specific antibody levels in serum were not affected by treatment. Because many of these responses may be influenced by dendritic cell function, we investigated the effect of R406 on bone marrow-derived dendritic cell (BMDC) function. Co-culture of BMDC with immune complexes of OVA and IgG anti-OVA together with OVA-sensitized spleen mononuclear cells resulted in increases in IL-13 production. IL-13 production was inhibited if the BMDCs were pretreated with the Syk inhibitor. Intratracheal transfer of immune complex-pulsed BMDCs (but not nonpulsed BMDCs) to naive mice before airway allergen challenge induced the development of AHR and increases in BAL eosinophils and lymphocytes. All of these responses were inhibited if the transferred BMDCs were pretreated with R406. These results demonstrate that Syk inhibition prevents allergen-induced AHR and airway inflammation after systemic sensitization and challenge, at least in part through alteration of DC function.
Mesh Headings (Keywords): Allergens, Animals, B-Lymphocytes, Bone Marrow Cells, Bronchial Hyperreactivity, Cells, Cultured, Coculture Techniques, Cytokines, Dendritic Cells, Enzyme Activation, Female, Goblet Cells, Inflammation, Interleukin-13, Intracellular Signaling Peptides and Proteins, Mast Cells, Metaplasia, Methacholine Chloride, Mice, Mice, Inbred BALB C, Ovalbumin, Oxazines, Protein-Tyrosine Kinases, Pyridines, Respiratory System
Check for Full Text / PubMed Unique Identifier (PMID): 16339999
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.